WELCOME TO OUR WEBSITE !    |   ABOUT US   |   CONTACT US
What are the risks of ERCP with intestinal stent placement?
You are here: Home » Blog » Intestinal stent » What are the risks of ERCP with intestinal stent placement?

BLOG SEARCH

What are the risks of ERCP with intestinal stent placement?

Views: 0     Author: Site Editor     Publish Time: 2025-05-12      Origin: Site

What are the risks of ERCP with intestinal stent placement?

ERCP with intestinal (biliary or pancreatic) stent placement is generally safe but does carry some risks and potential complications, especially since it’s a technically complex procedure. Below are the most common and serious risks:


Common Risks

  1. Pancreatitis (3–15% incidence)

    • Inflammation of the pancreas is the most frequent complication.

    • Can range from mild to severe, occasionally requiring hospitalization.

  2. Infection (Cholangitis or Abscess)

    • Bacterial infection of the bile ducts or pancreas, especially if drainage is incomplete.

    • Requires antibiotics and sometimes further drainage.

  3. Bleeding

    • May occur from sphincterotomy (if done) or from trauma during the procedure.

    • Usually mild but can require endoscopic or surgical intervention.

  4. Perforation

    • A tear in the esophagus, stomach, duodenum, or bile/pancreatic duct.

    • Rare but serious; may require surgery.

  5. Stent-related issues

    • Migration: Stent moves from its intended position.

    • Blockage or occlusion: Buildup of sludge or tumor tissue may re-block the duct.

    • Stent fracture: Mostly with plastic stents over long durations.


Other Risks

  • Allergic reaction to contrast dye or medications.

  • Aspiration during sedation (inhaling stomach contents into the lungs).

  • Anesthesia-related complications, particularly in elderly or medically fragile patients.


⚠️ Risk Factors That Increase Complication Rates

  • Prior pancreatitis

  • Difficult cannulation

  • Sphincter of Oddi dysfunction

  • Use of certain types of stents (e.g., uncovered SEMS in benign disease)

  • Poor overall health status or co-existing conditions


How Risks Are Minimized

  • Use of prophylactic antibiotics for infection prevention.

  • Use of rectal NSAIDs (e.g., indomethacin) to lower pancreatitis risk.

  • Careful technique by experienced endoscopists.

  • Close post-procedure monitoring for early detection of complications.


Would you like to know when stents should be removed or replaced after ERCP?


Contact us quickly to get the latest product quotation !
Leave a Message
Contact us

PRODUCTS

LINKS

CONTACT

Company Address: Room 302 , 3rd Floor, Building 6, No. 688, Bin an Road Hangzhou, China
Postal Code: 310052
Whatsapp/Wechat: +86-17767267187
Email:ljh@tangjimedical.com
Office:+86-571 87839895
Copyright © 2017-2022 Hangzhou Tangji Medical Technology Co., Ltd.. All rights reserved.